Skip to content
AnalystLens

Omega Healthcare Investors 8-K Report, Financial Results (Nov 3, 2026)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed November 3, 2026
Period End
November 3, 2026
Security
OHI
In the record · 2016–202610-K1210-Q348-K126

OHI filed 12 annual reports (10-K), 34 quarterly reports (10-Q) and 126 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · May ’17May ’17
  2. Material agreement8-K · Sep ’19Sep ’19
  3. Leadership change8-K · Jan ’22Jan ’22
  4. Leadership change8-K · Jan ’26Jan ’26

Summary

Summary of the 8-K filed November 3, 2026. Cited figures are marked; the original filing is the authoritative source.

Omega Healthcare Investors, Inc. ("Omega") furnished a press release on November 3, 2026 reporting third quarter 2026 results.

Net income was $87 milliona, or $0.27 per diluted share, versus $0.60 per basic share... more precisely, net income available to common stockholders was $83.1 million, or $0.27 per diluted share, for the quarter. AFFO was $262 million, or $0.82 per diluted share, compared with $243 million, or $0.79 per diluted share, in the third quarter of 2025. FAD was $250 million, or $0.78 per diluted share, versus $231 million, or $0.75 per diluted share, a year earlier.

NOI rose to $332 millionb from $310 million. Investment activity was active. Omega completed $182 million of investments in the third quarter and $946 million since quarter-end, bringing 2026 year-to-date investment activity to approximately $1.5 billion.

The largest post-quarter transaction was an $846 millionc U.K. mortgage loan to an affiliate of Foundation Partners Asset Management Limited, secured by 48 U.K. care homes and leasehold interests in 7 additional care homes, bearing interest at 8.72%. In October, Omega transitioned 32 Florida skilled nursing facilities to PACS Group, Inc. for a $90 million termination fee paid to the prior operator, adding $26.1 million of initial annual contractual rent. The Genesis Healthcare bankruptcy sale was finalized in October, with Omega's lease assumed by NewGen and $149.5 million received in repayment of DIP and term loans.

Management raised its 2026 AFFO per diluted share guidance to $3.28 to $3.30d, from $3.22 to $3.26, and declared a quarterly dividend of $0.68 per share payable November 16, 2026. As of September 30, 2026, total indebtedness was $4.1 billion at a weighted average interest rate of 4.2%, cash and cash equivalents were $195.9 million, and $2.0 billion was undrawn under the unsecured revolving credit facility. CEO Matthew Gourmand said leverage had been reduced to the lowest level in the Company's history.

Key Highlights

  1. Third quarter AFFO of $262 million, or $0.82 per diluted share, up from $243 million, or $0.79 per diluted share, in Q3 2025.
  2. Third quarter net income of $87 million, or $0.27 per diluted share, with NOI of $332 million versus $310 million a year earlier.
  3. Approximately $1.5 billion of 2026 year-to-date investments, including $946 million completed since quarter-end, led by an $846 million U.K. mortgage loan at 8.72%.
  4. 2026 AFFO per diluted share guidance raised to $3.28 to $3.30 from $3.22 to $3.26.
  5. Genesis Healthcare bankruptcy sale finalized in October 2026, with $149.5 million received in DIP and term loan repayments.
  6. 32 Florida SNFs transitioned to PACS Group, Inc. in October 2026, adding $26.1 million of first-year annual contractual rent after a $90 million termination fee.
  7. Quarterly dividend of $0.68 per share declared, payable November 16, 2026, with a record date of November 5, 2026.

Frequently Asked Questions

  1. How did Omega perform in the third quarter of 2026 compared with the prior year?

    AFFO rose to $262 million, or $0.82 per diluted share, from $243 million, or $0.79 per diluted share. FAD increased to $250 million, or $0.78 per diluted share, from $231 million, or $0.75 per diluted share. Net income was $87 million, or $0.27 per diluted share, compared with $185 million in the prior-year quarter, which included larger gains on asset sales.

  2. What drove the increase in 2026 AFFO guidance?

    Management raised its 2026 AFFO per diluted share range to $3.28 to $3.30 from $3.22 to $3.26. The guidance assumes all announced portfolio activity, including the new investments described in the release, and that no additional operators are placed on a cash basis. It excludes additional acquisitions, capital markets activity, interest refinancing expenses and credit loss provisions.

  3. What are the largest recent investments?

    The largest post-quarter investment is an $846 million U.K. mortgage loan, funded in November 2026, to an affiliate of Foundation Partners Asset Management Limited, secured by 48 U.K. care homes and leasehold interests in 7 more. The loan bears interest at 8.72%, rising to 8.94% in year two, and matures in November 2031. Omega has a purchase option on the underlying real estate that it expects to exercise when available.

  4. How is Omega's balance sheet positioned?

    As of September 30, 2026, Omega had $4.1 billion of outstanding indebtedness at a weighted average annual interest rate of 4.2%, consisting of $3.8 billion of senior unsecured notes and a $300.0 million term loan. It held $195.9 million of cash and cash equivalents and $2.0 billion of undrawn capacity under its unsecured revolving credit facility. Management stated that leverage was reduced to the lowest level in the Company's history.

  5. What do the Genesis and PACS transactions mean for Omega's rental income?

    NewGen, which acquired Genesis's assets, is expected to pay its full contractual rent of $13.3 million per quarter after assuming Omega's lease, which equates to approximately $14.0 million of straight-line revenue per quarter. The 32 Florida SNFs transitioned to PACS add initial annual contractual rent of $58.0 million, an increase of $26.1 million, rising by $2.5 million in year two and with 2% annual escalators thereafter through January 31, 2038.